Showing results (41-50 of 83) with videos related to
Sort By:
Pageof 9
BMC Cancer|April 9, 2014
Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancerAlexander B Philipp, Dorothea Nagel, Petra Stieber, et al.Anticancer Research|July 2, 2010
Clinical relevance of thymidine kinase for the diagnosis, therapy monitoring and prognosis of non-operable lung cancerStefan Holdenrieder, Joachim Von Pawel, Thomas Duell, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 4, 2005
Nucleosomes indicate the in vitro radiosensitivity of irradiated bronchoepithelial and lung cancer cellsStefan Holdenrieder, Jutta Stief, Albrecht Bergner, et al.Journal of Neurology|April 6, 2007
Nucleosomes as a new prognostic marker in early cerebral strokeSandra Geiger, Stefan Holdenrieder, Petra Stieber, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Methylation of serum DNA is an independent prognostic marker in colorectal cancerMaike Wallner, Andreas Herbst, Andrea Behrens, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 10, 2011
Kinetics of CEA and CA15-3 correlate with treatment response in patients undergoing chemotherapy for metastatic breast cancer (MBC)Dorit Di Gioia, Volker Heinemann, Dorothea Nagel, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancerHans Dieplinger, Donna Pauler Ankerst, Alexander Burges, et al.Cerebrovascular Diseases (Basel, Switzerland)|November 12, 2005
Nucleosomes in serum of patients with early cerebral strokeSandra Geiger, Stefan Holdenrieder, Petra Stieber, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 30, 2009
Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohortMiriam S Lenhard, Stefanie Mitterer, Carolin Kümper, et al.Clinical Chemistry and Laboratory Medicine|March 15, 2003
Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer?Brigitte Mahnert, Stephan Tauber, Martin Kriegmair, et al.Pageof 9